SOUTH SAN FRANCISCO, Calif., Sept. 14, 2022 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced that it intends to offer and sell up to $80.0 million of shares of its common stock in an underwritten public offering. In addition, IDEAYA intends to grant the underwriters…